NCAPG2 and TAL1

  • Number of citations of the paper that reports this interaction (PMID 14729962)
  • 2
  • Data Source:
  • HPRD (two hybrid)

NCAPG2

TAL1

Gene Name non-SMC condensin II complex, subunit G2 T-cell acute lymphocytic leukemia 1
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 1 interactors: TAL1 23 interactors: CHD3 DRG1 ELSPBP1 EP300 GATA1 GATA2 GATA3 HDAC1 HOXB9 KAT2B KDM1A LMO1 LMO2 MAPK3 NCAPG2 PRKCQ SIN3A SKP2 SP1 STUB1 TCF3 TCF4 ZHX1
Entrez ID 54892 6886
HPRD ID 10539 01753
Ensembl ID ENSG00000146918 ENSG00000162367
Uniprot IDs B3KRQ2 F5H7R2 Q86XI2 P17542
PDB IDs 2YPA 2YPB
Enriched GO Terms of Interacting Partners?
Tagcloud ?
adarb2  asymptomatic  carriers  carrying  ceacam6  cntnap2  col19a1  commonest  consider  def4  dopaminergic  draxin  fcer2  functionally  g2019s  hbg1  idiopathic  initiating  lrrk2  merit  never  parkinson  pd  pvrl2  seq  slc2a14  snca  tcl1b  variations 
activates  arrest  causes  complexed  contribute  e2a  expressing  fusion  heterodimers  inhibition  interferes  jurkat  leukemia  leukemic  line  lymphoblastic  model  oncogene  oncogenes  originally  postulates  proposed  restored  subsequently  suggests  supporting  suppressing  transcriptional  underwent 
Tagcloud (Difference) ?
adarb2  asymptomatic  carriers  carrying  ceacam6  cntnap2  col19a1  commonest  consider  def4  dopaminergic  draxin  fcer2  functionally  g2019s  hbg1  idiopathic  initiating  lrrk2  merit  never  parkinson  pd  pvrl2  seq  slc2a14  snca  tcl1b  variations 
activates  arrest  causes  complexed  contribute  e2a  expressing  fusion  heterodimers  inhibition  interferes  jurkat  leukemia  leukemic  line  lymphoblastic  model  oncogene  oncogenes  originally  postulates  proposed  restored  subsequently  suggests  supporting  suppressing  transcriptional  underwent 
Tagcloud (Intersection) ?